In massive hemorrhage from acute gastric mucosal lesions, it is occasionally difficult to control the bleeding with nonsurgical therapy. We used the somatostatin analog, octreotide, which suppresses gastric and pancreatic function, to treat severe hemorrhagic erosive gastritis in a patient with acute pancreatitis. A 22-year-old man presented with epigastralgia and melena. Blood levels of pancreatitis markers were elevated. Computed tomography revealed diffuse enlargement of the pancreas, without fluid collection around the organ. An endoscopic examination showed extensive hemorrhagic erosions over almost the whole gastric mucosa. We diagnosed extensive hemorrhagic erosive gastritis with acute pancreatitis. A protease inhibitor (nafamostat mesilate 50 mg/day) and an H2 receptor antagonist (famotidine 40 mg/day) were administered by injection for 6 days; the patient's serum and urine amylase levels fell, but the gastric erosions with hemorrhage were not attenuated. Octreotide was given subcutaneously, at a daily dose of 100 μg for 5 days, without famotidine administration. His melena disappeared, and the gastric erosions were markedly decreased. Administration of the somatostatin analog, octreotide, proved to be effective treatment in a patient with severe hemorrhagic erosive gastritis associated with acute pancreatitis.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: February 20, 2001 / Accepted: May 25, 2001
Reprint requests to: K. Yabuki
Rights and permissions
About this article
Cite this article
Yabuki, K., Maekawa, T., Satoh, K. et al. Extensive hemorrhagic erosive gastritis associated with acute pancreatitis successfully treated with a somatostatin analog. J Gastroenterol 37, 737–741 (2002). https://doi.org/10.1007/s005350200120
Issue Date:
DOI: https://doi.org/10.1007/s005350200120